However, both berberine and semaglutide have been shown in clinical trials to help cells respond better to insulin
In that study, patients taking a semaglutide drug like Ozempic regained 68% of the weight lost after 1 year off Ozempic
Your body thinks its starving to death. The breakthrough drugs counteract this by impersonating a hormone called glucagon-like peptide 1, or GLP-1, thats involved in appetite regulation
GLP-1RAs provide effective glucose control while promoting weight loss via effects on appetite and gastric emptying [11,12,13,14]
FDA's concerns with unapproved GLP-1 drugs used for weight loss
The option to continue or initiate treatment with approved AD medications during the trial, including cholinesterase inhibitors and recently approved anti-amyloid monoclonal antibody treatments that may be available during trial execution, will allow for important information to be gathered on the safety of concurrent use of these medications with different mechanisms of action and provides flexibility in an evolving therapeutic landscape
